BUGYCA
ActiveFrom the official registers: KBO 16 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
BUGYCA has been active since 2003 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 1 administrative register entry. The 2025 annual accounts show negative equity (-€182,568) and a net result of €13,681. Equity has been shrinking by about 24% per year since 2019. Its solvency ranks better than 5% of 783 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Overview
Official details
KBO- Status
- Active since 20-10-2003 Normal situation
- Activity
- Specialist medical practice NACE 86220
- Establishment unit
- 2.280.680.034 1090 Jette, since 20-10-2003
- Financial year end
- 30 June
- Peppol
- Not found in the Peppol Directory
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.3%
- Turnover
- €309,358
- Profit
- €13,681
- Equity
- -€182,568
- Total assets
- €534,425
- Staff
- ≈ 0.4 FTE
- estimated
Score breakdownraises riskCapped at 59: negative equityNegative equity -€182,568Last filed accounts filed 28 days late; 1 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Size: turnover €309,358, total assets €534,425Show the evidence
Checked score
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 1% of them on solvency, 5% on liquidity and 16% on profitability.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 106 days after the deadline. In the sector (NACE 86), the median for financial year 2023 was 5 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (1)
Financials
Financials · financial year 2025, full format
2025 annual accounts filed 27 days after the deadline Filed on 27 February 2026, deadline 31 January 2026 (7 months after the close on 30 June 2025, Companies Code art. 3:10). Source: NBB, 2026-00044843.
Annual accounts 2025 filed on 27-02-2026 PDF all 16 filings
2019 to 2025, 5 financial years 2019 to 2025, 5 financial years
The operating result for 2025 is €43,813, against €16,284 in 2023. Comparable figures for the intervening years are unavailable.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).
Comparable companies
These companies have the same main activity as BUGYCA: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €510,000 and €574,000, founded between 2002 and 2006.
| Company | Founded | Total assets | Equity | Gross margin | Turnover | Net result | FTE | Financial year |
|---|---|---|---|---|---|---|---|---|
| BUGYCA Jette | 2003 | €534,425 | -€182,568 | €124,751 | €309,358 | €13,681 | - | 2025 |
| DOCTEUR WALDEMAR WEISS Ukkel | 2006 | €511,937 | €385,722 | €122,267 | - | €74,100 | - | 2025 |
| Docteur Pierre Defresne Tournai | 2003 | €510,306 | €477,765 | €132,341 | - | €84,619 | - | 2025 |
| DOKTER MARTIEN VANDENBERGHE, PNEUMOLOOG Pepingen | 2005 | €516,984 | €484,762 | €117,581 | - | €39,853 | 0.8 | 2025 |
| DOKTER BART SCHOENMAEKERS Beveren-Kruibeke-Zwijndrecht | 2005 | €573,560 | €448,929 | €121,783 | - | €101,099 | - | 2025 |
| DR. GINO NAESSENS Kasterlee | 2002 | €557,555 | €430,930 | €135,791 | - | €80,133 | - | 2025 |
| DR. KARIN SCHOTTE Brugge | 2003 | €563,667 | €543,072 | €136,358 | - | €101,465 | - | 2025 |
They were chosen from the 8,159 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Companies with the same profile, two years later
Historical observationIn July 2024, 519 companies had the same profile as BUGYCA has now. Two years later, 2.9% had gone bankrupt and 91.7% were still going.
- Small
- 20 years or older
- negative equity
- a profit under 5% of the balance sheet
Another 1.5% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of BUGYCA itself is lower: 0.3% within 12 months. It rests on far more data about BUGYCA than the profile alone.
Test of the method
The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 519 companies, not a prediction for BUGYCA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
| Line | 2019 | 2020 | 2021 | 2023 | 2025 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | €231,856 | €227,587 | €270,709 | €284,506 | €309,358 | - |
| Goods, raw materials, services and sundry goods60/61 | - | - | €179,713 | €194,156 | €194,159 | - |
| Remuneration, social security and pensions62 | - | - | €9,608 | €11,751 | €15,611 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €29,311 | €35,765 | €45,337 | €64,665 | €60,579 | - |
| Other operating charges640/8 | - | - | €3,467 | €8,212 | €4,748 | - |
| Gross operating margin9900 | €37,625 | €56,712 | €90,996 | €100,911 | €124,751 | - |
| Operating profit (loss)9901 | -€15,544 | -€6,907 | €32,584 | €16,284 | €43,813 | - |
| Financial income75/76B | - | - | - | €11 | €179 | - |
| Recurring financial income75 | €9 | €3 | - | €11 | €179 | - |
| Financial charges65/66B | - | - | €18,258 | €36,873 | €23,391 | - |
| Recurring financial charges65 | €14,188 | €20,189 | €18,258 | €36,873 | €23,391 | - |
| Profit (loss) for the period before taxes9903 | -€29,723 | -€27,092 | €14,326 | -€20,578 | €20,601 | - |
| Income taxes67/77 | -€1,678 | €12,001 | €8,492 | -€5,472 | €6,921 | - |
| Profit (loss) for the period9904 | -€28,045 | -€39,093 | €5,834 | -€15,106 | €13,681 | - |
| Profit (loss) for the period to be appropriated9905 | -€28,045 | -€39,093 | €5,834 | -€15,106 | €13,681 | - |
| Line | 2019 | 2020 | 2021 | 2023 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €239,600 | €438,105 | €442,429 | €596,566 | €534,425 | - |
| Fixed assets21/28 | €126,611 | €266,201 | €265,076 | €456,890 | €351,038 | - |
| Tangible fixed assets22/27 | €126,561 | €266,151 | €265,026 | €456,840 | €350,988 | - |
| Land and buildings22 | - | - | €244,195 | €449,893 | €348,053 | - |
| Plant, machinery and equipment23 | - | - | €8,498 | €6,947 | €817 | - |
| Furniture and vehicles24 | - | - | €12,333 | - | €2,118 | - |
| Leasing and similar rights25 | - | - | - | - | €0 | - |
| Financial fixed assets28 | €50 | €50 | €50 | €50 | €50 | - |
| Current assets29/58 | €112,989 | €171,904 | €177,353 | €139,676 | €183,387 | - |
| Amounts receivable within one year40/41 | €18,000 | - | €3,879 | €17,169 | €19,697 | - |
| Trade receivables40 | - | - | €3,879 | €8,740 | €8,740 | - |
| Other amounts receivable41 | - | - | - | €8,428 | €10,957 | - |
| Cash at bank and in hand54/58 | €27,123 | €96,212 | €78,715 | €32,716 | €62,707 | - |
| Deferred charges and accrued income490/1 | - | - | €94,759 | €89,791 | €100,984 | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €239,600 | €438,105 | €442,429 | €596,566 | €534,425 | - |
| Equity10/15 | -€55,180 | -€94,273 | -€88,439 | -€174,238 | -€182,568 | - |
| Contributions10/11 | €6,200 | €6,200 | €6,200 | €6,200 | €8,060 | - |
| Capital10 | - | - | €6,200 | €6,200 | - | - |
| Issued capital100 | - | - | €18,600 | €18,600 | - | - |
| Uncalled capital101 | - | - | €12,400 | €12,400 | - | - |
| Reserves13 | €1,860 | €1,860 | €1,860 | €1,860 | - | - |
| Non-distributable reserves130/1 | - | - | €1,860 | €1,860 | - | - |
| Legal reserve130 | - | - | €1,860 | €1,860 | - | - |
| Profit (loss) carried forward14 | -€63,240 | -€102,333 | -€96,499 | -€182,298 | -€190,628 | - |
| Amounts payable17/49 | €294,781 | €532,378 | €530,868 | €770,804 | €716,992 | - |
| Amounts payable after more than one year17 | - | €213,523 | €187,400 | €423,073 | €350,352 | - |
| Financial debts170/4 | - | - | €187,400 | €423,073 | €350,352 | - |
| Amounts payable within one year42/48 | €294,781 | €318,855 | €343,468 | €347,731 | €366,640 | - |
| Current portion of amounts payable after more than one year42 | - | - | €35,125 | €44,578 | €47,309 | - |
| Trade debts44 | €19,971 | €15,848 | €24,646 | €4,044 | €11,806 | - |
| Suppliers440/4 | - | - | €24,646 | €4,044 | €11,806 | - |
| Taxes, remuneration and social security45 | - | - | €18,959 | €25,819 | €31,739 | - |
| Taxes450/3 | - | - | €15,994 | €23,991 | €27,846 | - |
| Remuneration and social security454/9 | - | - | €2,965 | €1,827 | €3,893 | - |
| Other amounts payable47/48 | - | - | €264,738 | €273,290 | €275,786 | - |
| Line | 2019 | 2020 | 2021 | 2023 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€28,045 | -€39,093 | €5,834 | -€15,106 | €13,681 | - |
| + Depreciation and write-downs630 | €29,311 | €35,765 | €45,337 | €64,665 | €60,579 | - |
| Operating cash flow (approximation) | €1,267 | -€3,327 | €51,171 | €49,558 | €74,260 | - |
| Investment in fixed assets (approximation) | - | -€175,355 | -€44,212 | - | - | - |
| Change in cash | - | €69,089 | -€17,497 | - | - | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Latest 10 of 16 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 30-06-2025 | full format | 27-02-2026 | 2026-00044843 | |
| 30-06-2023 | full format | 08-02-2024 | 2024-00028476 | |
| 30-06-2021 | micro format | 15-06-2022 | 2022-20072647 | |
| 30-06-2020 | full format | 28-02-2021 | 2021-06500505 | |
| 30-06-2019 | full format | 31-12-2019 | 2019-77900195 | |
| 30-06-2018 | full format | 09-05-2019 | 2019-13100045 | |
| 30-06-2017 | full format | 24-05-2019 | 2019-14300226 | |
| 30-06-2016 | full format | 24-05-2019 | 2019-14300227 | |
| 30-06-2014 | full format | 31-12-2014 | 2014-71400383 | |
| 30-06-2013 | full format | 31-03-2014 | 2014-08600142 |
Board & ownership
Directors
Owners and capital
Capital transactions
- 30-06-2023 Converted to unavailable equity
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| BUKERA Aline |
|
Articles of association
Board and representation
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “1, administrateur doit être médecin actionnaire”
Capital, shares and profit
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- “Nominatives, effet vis-à-vis société et tiers qu’à dater inscription au registre”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Dossiers médicaux remis à médecins et continuité soins assurée, signalée au préalable au Conseil provincial de l’Ordre des Médecins”
- Share issue ruleThe articles set how and by whom new shares are issued.
- “Courrier électronique,ou courrier ordinaire même jour pour personnes sans adresse électronique, offertes par priorité aux actionnaires ayant…”
- Membership ruleThe articles set who can become a member or partner, and on what terms.
- “Médecins légalement habilités à exercer l'art de guérir en Belgique,inscrit au tableau de l’Ordre des Médecins et pratiquant ou appelés à…”
Articles of association, deed of 30-06-2023 (in French)
Network & group
BUGYCA shares no director with another company.
Connections & network
1 current directorThe network starts from the directors of BUGYCA. Every other company they run is a node.
Timeline
Acts, filings and financial milestones
30-06
Gazette deed
Resignation: BUKERA Aline (manager)Appointment: BUKERA Aline (director) · Capital conversion · Capital10 points ▸
- General meeting, 22-06-2023, mentioned 2 times in the deed
- Capital conversion, “compte de capitaux propres statutairement indisponible, compte de capitaux propres apports non appelés” (deed in French)
- Capital conversion, “formes et majorités de la modification des statuts, supprimer” (deed in French)
- Capital
- Director resignation, BUKERA Aline (manager)
- Director appointment, BUKERA Aline (director (not named in the articles))
- Director discharge, BUKERA Aline (gérant démissionnaire)
- Registered office clause, “Drève de Dieleghem 38, Jette (1090 Bruxelles)” (deed in French)
- Power of attorney
- Power of attorney, Catherine HATERT
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Activities
NACEBEL 2025Invoicing and payment
Financial year and general meeting
Accounts at the NBBRecognitions · licences · registrations
Legal Entity Identifier
Sites & property
1 establishment unit
Buildings and parcels at the address
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21010A0086/00P006 | Brussels | 793 m² | 1 · 155 m² | 8.7 m · 2 |